Home›Screener›TNGX›Profile
D
40/100

Tango Therapeutics, Inc.

TNGXBiotech / Pharma
← Signals View
📋
Analyst Summary
✓ VERIFIED2026-04-11

Tango Therapeutics, Inc. (TNGX) is the lead sponsor of 5 active clinical trials listed on ClinicalTrials.gov[3], including 5 Phase 2[1], 5 Phase 1[2].

TNGX has 2 Form 4 insider filings recorded at the SEC in the past 30 days[4].

Sources

  1. ClinicalTrials.gov (2026-04-11) ↗
  2. ClinicalTrials.gov (2026-04-11) ↗
  3. ClinicalTrials.gov (2026-04-11) ↗
  4. SEC EDGAR · 0001819133 (2026-04-11) ↗
🔬
Clinical Trials
5
NCT05275478Locally Advanced Solid Tumor
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05732831Locally Advanced Solid Tumor
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05887492Non Small Cell Lung Cancer, Solid Tumors, Adult, Lung Cancer, Lung Adenocarcinoma
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06810544Non Small Cell Lung Cancer, Glioma Glioblastoma Multiforme, Glioma, Malignant, Solid Tumor, Non-Small Cell Adenocarcinoma, Lung Cancer, Brain Tumor
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06922591PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, NSCLC, RAS Mutation, MTAP Deletion, Lung Cancer, Pancreatic Cancer Metastatic, Thoracic Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
👤
Insider Activity
1
2 filings
Source ↗
sec_edgar · Retrieved 2026-04-11
Not financial advice. BiotechSigns profiles are AI-generated from verified public sources (ClinicalTrials.gov, SEC EDGAR) and are for informational purposes only. Always do your own due diligence before making investment decisions.
Score Breakdown
Score Trend
2026-04-132026-06-02
Signal Summary
PDUFA Dates0
Insider Filings1
Clinical Trials1
Sector Peers (Biotech / Pharma)
ADILAdial Pharmaceuticals, Inc
A
HAOHaoxi Health Technology Limited Class A
A
PBMPsyence Biomedical Ltd. Common Shares
A
IKTInhibikase Therapeutics, Inc.
A
PALIPalisade Bio, Inc.
A
Data Provenance
cik1 verified
clinical trial5 verified
insider buy1 verified
trial count3 verified
Every claim backed by source URL from ClinicalTrials.gov or SEC EDGAR